ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
The Royal Marsden at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
The Royal Marsden takes part in 39 sessions at ESMO 2026 in Madrid. Its program spans treatment and supportive care across cancer types, with attention to biomarkers and precision oncology. It explores how shared and tumour-specific neoantigens can help select T-cell receptors.
| Organization | ESMO 2026 Attendance |
|---|---|
The Royal Marsden London, United Kingdom | |
NHS specialist cancer hospital with sites in London and Sutton, England, partnered with the Institute of Cancer Research. | Poster Fri Oct 23 13:00–15:00 Eltrombopag for chemotherapy-induced thrombocytopenia (CIT) in advanced gastrointestinal (GI) cancers: A retrospective analysis Gastrointestinal cancersNursing & supportive care Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Supportive oncology for patients with malignant melanoma: A service evaluation Melanoma & skin cancersNursing & supportive care Poster Fri Oct 23 13:00–15:00 Transforming supportive care for people living with lung cancer who have never smoked Lung & thoracic cancersNursing & supportive care Chair Fri Oct 23 13:30–15:00 Melanoma: From standard fit to bespoke care Melanoma & skin cancers Chair Fri Oct 23 13:30–15:00 Rapid oral: Genitourinary tumours, prostate, penile and testis Genitourinary cancersGastrointestinal cancers Abstract Fri Oct 23 13:45–13:57 Invited Discussant 1209RO, 1210RO and 2217RO Genitourinary cancersGastrointestinal cancers Talk Fri Oct 23 13:50–14:10 Shared and private neoantigen selection: Matchmaking TCRs Melanoma & skin cancers Poster Fri Oct 23 15:15–16:00 Chair Fri Oct 23 15:15–16:00 Chair Fri Oct 23 16:15–17:45 Talk Fri Oct 23 16:15–16:20 Introduction Nursing & supportive care Abstract Fri Oct 23 17:00–17:10 Talk Fri Oct 23 17:10–17:25 DC programme overview: Where we are and where we are going Nursing & supportive care Chair Sat Oct 24 10:15–11:45 ESMO Clinical Practice Guidelines 1 Gastrointestinal cancersGynaecological cancers Chair Sat Oct 24 10:15–11:30 Multidisciplinary insights for effective care in gynaecological sarcomas Sarcoma, CNS, head & neck and rare cancers Talk Sat Oct 24 10:15–10:20 Presentation of case/condition Sarcoma, CNS, head & neck and rare cancers Abstract Sat Oct 24 11:20–11:32 Invited Discussant LBA53 and 2045O Genitourinary cancers Poster Sat Oct 24 12:00–12:45 Poster Sat Oct 24 12:00–12:45 Breast cancer leptomeningeal disease, have we improved? A 20-year single centre-experience Breast cancerSarcoma, CNS, head & neck and rare cancers Satellite Sat Oct 24 13:10–13:20 Impact of Peri operative IO in LA HNSCC: From Biological Rationale to Clinical Outcomes Sarcoma, CNS, head & neck and rare cancers Satellite Sat Oct 24 13:40–14:10 MDT Case Discussion Sarcoma, CNS, head & neck and rare cancers Abstract Sat Oct 24 15:05–15:17 Invited Discussant LBA89 and 3715O Sarcoma, CNS, head & neck and rare cancers Satellite Sat Oct 24 18:30–20:00 Satellite Sat Oct 24 18:30–18:35 Welcome and Introduction Gynaecological cancers Satellite Sat Oct 24 19:15–19:35 Precision in Practice – Navigating Biomarkers and Sequencing Gynaecological cancers Satellite Sat Oct 24 19:35–19:50 Future Directions and Case-Based Application Gynaecological cancers Chair Sun Oct 25 08:30–10:00 Proffered paper: Head and neck cancer Sarcoma, CNS, head & neck and rare cancers Abstract Sun Oct 25 09:38–09:50 Invited Discussant LBA44, LBA45 and 1535O Sarcoma, CNS, head & neck and rare cancers Abstract Sun Oct 25 10:15–10:25 Talk Sun Oct 25 10:15–10:30 Black women's views and experiences of making lifestyle changes following breast cancer treatment Nursing & supportive care Chair Sun Oct 25 10:15–11:45 ESMO Clinical Practice Guidelines 2 Breast cancerGenitourinary cancers Chair Sun Oct 25 10:15–11:15 Talk Sun Oct 25 10:15–10:20 Talk Sun Oct 25 11:05–11:15 Poster Sun Oct 25 12:00–12:45 Does Europe still generate its own evidence? Patient enrollment in pivotal trials for EMA solid tumour approvals, 2020-2025 Gastrointestinal cancersGynaecological cancersLung & thoracic cancersGenitourinary cancers Poster Sun Oct 25 12:00–12:45 Poster Sun Oct 25 12:00–12:45 Pan-cancer clinico-genomic machine learning for survival prediction following immune checkpoint inhibitor therapy Biomarkers & precision oncology Poster Sun Oct 25 12:00–12:45 Satellite Sun Oct 25 13:00–14:30 Satellite Sun Oct 25 13:00–13:05 Welcome and introduction Breast cancer Satellite Sun Oct 25 13:05–13:25 Chair Sun Oct 25 14:45–16:15 Rapid oral 2: Genitourinary tumours, renal and urothelial Genitourinary cancers Abstract Sun Oct 25 15:54–16:06 Invited Discussant 3593RO, 3594RO and 3595RO Genitourinary cancers Chair Sun Oct 25 16:30–18:00 Rapid oral: Supportive and palliative care Nursing & supportive care Abstract Sun Oct 25 17:45–17:55 Invited Discussant 3087RO, 3088RO, 3898RO Nursing & supportive care Talk Mon Oct 26 09:10–09:30 Poster Mon Oct 26 12:00–12:45 Lanreotide in grade 2 GEP-NETs: Real-world efficacy according to Ki-67 index Gastrointestinal cancersSarcoma, CNS, head & neck and rare cancers Poster Mon Oct 26 12:00–12:45 Prognostic value of platelet-to-lymphocyte ratio in gastroenteropancreatic and pulmonary neuroendocrine tumours Gastrointestinal cancersSarcoma, CNS, head & neck and rare cancersLung & thoracic cancers Chair Mon Oct 26 12:00–12:50 What oncologists should know about interpreting tumour sequencing Biomarkers & precision oncology Talk Mon Oct 26 12:15–12:30 Liquid biopsy and CHIP: What clinicians need to know Biomarkers & precision oncology Satellite Mon Oct 26 13:25–13:50 Real-world experience: Challenges & strategies in treating DTs Sarcoma, CNS, head & neck and rare cancers Chair Mon Oct 26 14:45–16:15 Talk Mon Oct 26 14:45–15:05 Abstract Mon Oct 26 15:43–15:53 Talk Mon Oct 26 15:45–16:05 Local treatments for imatinib-resistant GIST: Implications of broad KIT inhibition Sarcoma, CNS, head & neck and rare cancers Talk Mon Oct 26 15:45–16:05 MRD to inform treatment decision Breast cancer Chair Tue Oct 27 09:00–13:00 |
Find decision makers at The Royal Marsden
Tell us what you sell and we’ll find the people at The Royal Marsden most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction